Sign up to save your podcasts
Or
Share Episode 13: A Between the Biotech Waves Conversation with Vic Myer, President and CSO at Chroma Medicine
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 13: A Between the Biotech Waves Conversation with Vic Myer, President and CSO at Chroma Medicine
Today we talk to Vic Myer, xChief Technology Officer at Editas, currently President and CSO at Chroma Medicine. We discuss the state of genome editing and the potential for chromatin modification.
View all episodes
By Nessan Bermingham PhD
4.9
2121 ratings
Today we talk to Vic Myer, xChief Technology Officer at Editas, currently President and CSO at Chroma Medicine. We discuss the state of genome editing and the potential for chromatin modification.
More shows like Between the Biotech Waves
View all
WSJ What’s News
4,333 Listeners
WSJ Your Money Briefing
1,714 Listeners
Marketplace
8,634 Listeners
Acquired
4,228 Listeners
Odd Lots
1,866 Listeners
Animal Spirits Podcast
1,997 Listeners
The Indicator from Planet Money
9,507 Listeners
The Readout Loud
316 Listeners
The Long View
883 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
30 Listeners
Raising Health
144 Listeners
Biotech Hangout
18 Listeners
Ground Truths
50 Listeners
Money Stuff: The Podcast
378 Listeners